Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

THOMAS A LUPOLI

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1174717276
CMS profile
189671
Location
ORANGE PARK, FL

General Payments · PY2018–2024

$6,954.66

  • Reported across 298 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$806.68

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $806.68 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,171.56 49
PY2019 $1,446.89 56
PY2020 $789.68 33
PY2021 $794.26 40
PY2022 $966.19 42
PY2023 $979.40 42
PY2024 $806.68 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $23.73 01/10/2024 Food and Beverage Undisputed 01/23/2026 1105534630 CMS
AstraZeneca Pharmaceuticals LP $22.28 01/16/2024 Food and Beverage Undisputed 01/23/2026 1105829735 CMS
AstraZeneca Pharmaceuticals LP $21.38 04/17/2024 Food and Beverage Undisputed 01/23/2026 1104340054 CMS
AstraZeneca Pharmaceuticals LP $27.14 05/28/2024 Food and Beverage Undisputed 01/23/2026 1104597672 CMS
AstraZeneca Pharmaceuticals LP $25.66 06/26/2024 Food and Beverage Undisputed 01/23/2026 1104452072 CMS
AstraZeneca Pharmaceuticals LP $25.02 08/13/2024 Food and Beverage Undisputed 01/23/2026 1104627872 CMS
AstraZeneca Pharmaceuticals LP $2.83 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105291169 CMS
AstraZeneca Pharmaceuticals LP $15.14 10/15/2024 Food and Beverage Undisputed 01/23/2026 1105841749 CMS
AstraZeneca Pharmaceuticals LP $24.07 10/29/2024 Food and Beverage Undisputed 01/23/2026 1104212805 CMS
AstraZeneca Pharmaceuticals LP $30.42 11/26/2024 Food and Beverage Undisputed 01/23/2026 1105747737 CMS
BioCryst US Sales Co., LLC $22.64 05/14/2024 Food and Beverage Undisputed 01/23/2026 1117480894 CMS
Blueprint Medicines Corporation $24.21 03/26/2024 Food and Beverage Undisputed 01/23/2026 1147455905 CMS
CSL Behring $21.01 05/22/2024 Food and Beverage Undisputed 01/23/2026 1134612899 CMS
CSL Behring $14.37 08/27/2024 Food and Beverage Undisputed 01/23/2026 1134612923 CMS
CSL Behring $30.42 11/07/2024 Food and Beverage Undisputed 01/23/2026 1134612943 CMS
GlaxoSmithKline, LLC. $24.24 07/15/2024 Food and Beverage Undisputed 01/23/2026 1116061454 CMS
Grifols USA, LLC $13.92 01/18/2024 Food and Beverage Undisputed 01/23/2026 1124736174 CMS
Grifols USA, LLC $15.88 04/11/2024 Food and Beverage Undisputed 01/23/2026 1124736176 CMS
Grifols USA, LLC $22.47 07/09/2024 Food and Beverage Undisputed 01/23/2026 1124736178 CMS
Novartis Pharmaceuticals Corporation $19.69 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087066620 CMS
Novartis Pharmaceuticals Corporation $23.21 07/30/2024 Food and Beverage Undisputed 01/23/2026 1087066626 CMS
Octapharma USA, Inc. $14.90 02/14/2024 Food and Beverage Undisputed 01/23/2026 1142316605 CMS
Optinose US, Inc. $20.13 02/13/2024 Food and Beverage Undisputed 01/23/2026 1142172690 CMS
Optinose US, Inc. $22.86 09/10/2024 Food and Beverage Undisputed 01/23/2026 1142172784 CMS
PFIZER INC. $24.89 04/30/2024 Food and Beverage Undisputed 01/23/2026 1131322350 CMS
Pharming Healthcare, Inc. $17.17 07/23/2024 Food and Beverage Undisputed 01/23/2026 1132155603 CMS
Pharming Healthcare, Inc. $25.45 11/19/2024 Food and Beverage Undisputed 01/23/2026 1132155611 CMS
Regeneron Healthcare Solutions, Inc. $39.46 01/30/2024 Food and Beverage Undisputed 01/23/2026 1114104461 CMS
Regeneron Healthcare Solutions, Inc. $0.37 01/30/2024 Food and Beverage Undisputed 01/23/2026 1114104463 CMS
Regeneron Healthcare Solutions, Inc. $27.61 03/11/2024 Food and Beverage Undisputed 01/23/2026 1114104465 CMS
Regeneron Healthcare Solutions, Inc. $2.75 03/12/2024 Food and Beverage Undisputed 01/23/2026 1114104467 CMS
Regeneron Healthcare Solutions, Inc. $31.87 04/09/2024 Food and Beverage Undisputed 01/23/2026 1114104469 CMS
Regeneron Healthcare Solutions, Inc. $34.87 06/18/2024 Food and Beverage Undisputed 01/23/2026 1114104471 CMS
Regeneron Healthcare Solutions, Inc. $36.22 10/22/2024 Food and Beverage Undisputed 01/23/2026 1114104473 CMS
Regeneron Healthcare Solutions, Inc. $38.60 11/12/2024 Food and Beverage Undisputed 01/23/2026 1114104475 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.80 09/17/2024 Food and Beverage Undisputed 01/23/2026 1137625484 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.